The resveratrol analogue 4,4′-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol
- 31 December 2009
- journal article
- Published by Elsevier BV in The International Journal of Biochemistry & Cell Biology
- Vol. 41 (12), 2493-2502
- https://doi.org/10.1016/j.biocel.2009.08.005
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in MicePLOS ONE, 2008
- In Vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogsCellular & Molecular Biology Letters, 2008
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Proteasome-independent down-regulation of estrogen receptor-α (ERα) in breast cancer cells treated with 4,4′-dihydroxy-trans-stilbeneBiochemical Pharmacology, 2006
- Structure–activity relationship studies of resveratrol and its analogues by the reaction kinetics of low density lipoprotein peroxidationBioorganic Chemistry, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analoguesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- The Cyclin-Dependent Kinase Inhibitors Olomoucine and Roscovitine Arrest Human Fibroblasts in G1 Phase by Specific Inhibition of CDK2 Kinase ActivityExperimental Cell Research, 1998
- Bypass of Senescence After Disruption of p21
CIP1/WAF1
Gene in Normal Diploid Human FibroblastsScience, 1997
- Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982